Related Experiment Video
Updated: Jan 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
IL-Iβ+3954 C/T Polymorphism and Its Clinical Associations in Egyptian Sickle Cell Disease Patients
Rasha Abdel-Raouf Abdel-Aziz Afifi1, Yasser Mohamad Sedky1, Hesham Abd-ELKareem2
1Department of Pediatrics, Cairo University, Cairo, Egypt.
Insights
The study found a higher prevalence of a specific Interleukin-1 beta (IL-1β) gene variant in Egyptian sickle cell disease (SCD) patients. This variant was linked to increased pulmonary hypertension risk in SCD patients.
Area of Science:
- Genetics
- Hematology
- Immunology
Background:
- Sickle cell disease (SCD) is an inherited hemolytic anemia causing chronic inflammation and reduced quality of life.
- Interleukin-1 beta (IL-1β) plays a role in inflammatory diseases, and its single nucleotide polymorphisms (SNPs) may predict disease prognosis.
- IL-1β (+3954C/T) SNP is investigated for its potential role in modifying SCD phenotypes.
Purpose of the Study:
- To investigate the IL-1β (+3954C/T) single nucleotide polymorphism (SNP) as a potential genetic modifier in sickle cell disease (SCD).
- To explore the association between IL-1β (+3954C/T) SNP and clinical and laboratory features of SCD patients.
Main Methods:
- A cross-sectional study involving 50 SCD patients and 50 healthy controls.
- Genotyping of IL-1β (+3954C/T) SNP using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
- Analysis of associations between the IL-1β (+3954C/T) SNP and SCD clinical and laboratory profiles.
Main Results:
- The homozygous mutant genotype (TT) for IL-1β (+3954C/T) SNP was significantly more prevalent in SCD patients (26%) compared to controls (6%).
- The TT genotype was associated with significantly higher mean pulmonary arterial pressure (42.62 mmHg) in SCD patients compared to CC and CT genotypes (33.49 mmHg).
Conclusions:
- An increased prevalence of the IL-1β +3954 SNP mutant genotype was observed in Egyptian SCD patients.
- The IL-1β +3954 SNP mutant genotype was more common in SCD patients with pulmonary hypertension, suggesting a role in disease complications.
- These findings indicate a potential role for IL-1β +3954 SNP in the pathophysiology and manifestations of sickle cell disease.
Abstract:
Background: Sickle cell disease (SCD) is a hereditary disorder characterized by hemolytic anemia with different clinical manifestations. Patients with SCD exhibit a chronic inflammatory state and reduced length and quality of life. Interleukin-1 β (IL-1β) is important in acute and chronic diseases; and its single nucleotide polymorphisms (SNP) have been considered as predictors of prognosis in several inflammatory conditions. This study aimed at exploring IL-1β (+3954C/T) SNP as a potential genetic modifier and/or predictor of SCD clinical and laboratory phenotypes. Materials and Methods: This cross-sectional study involved 50 SCD patients and 50 age, sex and ethnicity-matched healthy individuals. IL-1β (+3954C/T) SNP was identified by PCR-RFLP. Associations between IL-1β (+3954 C/T) SNP and the clinical and laboratory profiles of patients with SCD were studied. Results: It was found that the homozygous mutant genotype TT was significantly higher in cases compared to controls [13(26%) vs. 3(6%) respectively; p=0.006, OR (95%CI): 5.505(1.460-20.756)]. The homozygous mutant genotype TT was associated with a higher mean pulmonary arterial pressure when compared to the CC and CT genotype (42.62 vs. 33.49 mmHg, p<0.001). Conclusion: There is an increased prevalence of the mutant genotype of IL-1β +3954 SNP in Egyptian SCD patients. Regarding disease complications, the mutant genotype was more prevalent in cases complicated by pulmonary hypertension. These findings point to the possible role of IL-1β +3954 SNP in the pathophysiology of SCD and its manifestations.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Coronary Artery Disease III: Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Single Nucleotide Polymorphisms-SNPs

